GABLOFEN: payments to doctors
Payments that named GABLOFEN as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.4M
- Providers
- 848
- Transactions
- 7,786
- Average per transaction
- $179
The per-transaction average — $179 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 848 providers the average total is $1,639, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Piramal Critical CARE | $1,193,215 | 85.8% |
| Piramal Critical Care | $196,939 | 14.2% |